JP2012519003A - 不妊症関連ｄｅｆｂ−１２６欠失多型 - Google Patents

不妊症関連ｄｅｆｂ−１２６欠失多型 Download PDF

Info

Publication number
JP2012519003A
JP2012519003A JP2011552196A JP2011552196A JP2012519003A JP 2012519003 A JP2012519003 A JP 2012519003A JP 2011552196 A JP2011552196 A JP 2011552196A JP 2011552196 A JP2011552196 A JP 2011552196A JP 2012519003 A JP2012519003 A JP 2012519003A
Authority
JP
Japan
Prior art keywords
defb
polypeptide
seq
sperm
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011552196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012519003A5 (https=
Inventor
チャールズ エル． ベビンス
ツァン ラウ
ゲイリー エヌ． シェール
アシュレー アイ． ユージン
セオドア エル． トルナー
ジェイムス ダブリュ． オーバーストリート
スコット ベナーズ
シピン スー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of JP2012519003A publication Critical patent/JP2012519003A/ja
Publication of JP2012519003A5 publication Critical patent/JP2012519003A5/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
JP2011552196A 2009-02-26 2010-02-26 不妊症関連ｄｅｆｂ−１２６欠失多型 Ceased JP2012519003A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15580709P 2009-02-26 2009-02-26
US61/155,807 2009-02-26
PCT/US2010/025626 WO2010099468A2 (en) 2009-02-26 2010-02-26 Infertility associated defb-126 deletion polymorphism

Publications (2)

Publication Number Publication Date
JP2012519003A true JP2012519003A (ja) 2012-08-23
JP2012519003A5 JP2012519003A5 (https=) 2013-04-11

Family

ID=42666247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011552196A Ceased JP2012519003A (ja) 2009-02-26 2010-02-26 不妊症関連ｄｅｆｂ−１２６欠失多型

Country Status (5)

Country Link
US (1) US20120077758A1 (https=)
EP (1) EP2401407A4 (https=)
JP (1) JP2012519003A (https=)
CA (1) CA2789941A1 (https=)
WO (1) WO2010099468A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021020498A1 (https=) * 2019-07-31 2021-02-04

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012133127A1 (ja) * 2011-03-31 2014-07-28 株式会社グライエンス ブドウ球菌属内の菌種を判別する方法
CN103468807B (zh) * 2013-09-12 2015-07-15 上海惠宝生物科技有限公司 用于检测男性生育力的引物、探针及其试剂盒
JP6852397B2 (ja) * 2016-12-28 2021-03-31 株式会社島津製作所 分析用試料の調製方法および分析方法
EP3850112A1 (en) 2018-09-11 2021-07-21 Università degli Studi di Foggia Method for identifying the predisposition to male infertility based on polymorphisms of the vitamin d receptor gene
CN114606310A (zh) * 2022-03-23 2022-06-10 上海市生物医药技术研究院 人defb126基因移码突变检测方法和试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070299025A1 (en) * 2004-01-15 2007-12-27 Oy Jurilab Ltd Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070299025A1 (en) * 2004-01-15 2007-12-27 Oy Jurilab Ltd Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN5012010090; ＧＥＮＢＡＮＫ: 'ＨＯＭＯ　ＳＡＰＩＥＮＳ　ＭＲＮＡ　ＦＯＲ　ＢＥＴＡ　ＤＥＦＥＮＳＩＮ　１２６　ＰＲＥＰＲＯＰＲＯＴＥＩＮ　ＶＡＲＩＡＮＴ，ＣＬＯＮＥ：　ＦＣＣ１１１Ｅ１１' ［ＯＮＬＩＮＥ］ , 2006 *
JPN6014030798; Ｈｕｍ．　Ｒｅｐｒｏｄ．，　２００８，　２３（１１），　ｐｐ．２５２３-２５３４ *
JPN6014030799; ＥＭＢＯ　Ｊ．，　２００７，　２６（９），　ｐｐ．２３２７-２３３８ *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021020498A1 (https=) * 2019-07-31 2021-02-04
WO2021020498A1 (ja) * 2019-07-31 2021-02-04 スピンシェル株式会社 レポーティング装置、レポーティング方法、レポーティングプログラム、及びレポーティングシステム
JP7304020B2 (ja) 2019-07-31 2023-07-06 スピンシェル株式会社 レポーティング装置、レポーティング方法、レポーティングプログラム、及びレポーティングシステム
JP2023107999A (ja) * 2019-07-31 2023-08-03 スピンシェル株式会社 レポーティング装置、レポーティング方法、レポーティングプログラム、及びレポーティングシステム
US12327621B2 (en) 2019-07-31 2025-06-10 Spinshell, Inc. Reporting device, reporting method, reporting program, and reporting system

Also Published As

Publication number Publication date
WO2010099468A3 (en) 2010-11-18
WO2010099468A2 (en) 2010-09-02
CA2789941A1 (en) 2010-09-02
EP2401407A4 (en) 2012-10-03
EP2401407A2 (en) 2012-01-04
US20120077758A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
US20080113340A1 (en) Diagnosis and treatment of cervical cancer
JP6285472B2 (ja) 診断及び治療のための腫瘍関連マーカーの同定
JP2012519003A (ja) 不妊症関連ｄｅｆｂ−１２６欠失多型
CN104619840A (zh) Fgfr2融合基因
US20110020810A1 (en) Trpc6 involved in glomerulonephritis
JP2003514541A (ja) １８個のヒト分泌タンパク質
WO2004069268A1 (ja) Ｏｔｘ２遺伝子を用いた網膜視細胞の再生と新生
JPH10509581A (ja) トロフィニンおよびトロフィニン補助タンパク質
JP2008237204A (ja) 疾患モデル動物、細胞、組織、精巣、交配用動物、生殖細胞生産方法、生殖細胞、培養細胞、スクリーニング方法、医薬組成物、妊孕性診断キット、検出方法、ポリヌクレオチド、ポリペプチド、及び抗体
JP2002543761A (ja) 結核症抗原およびそのための使用の方法
KR101789910B1 (ko) 쇼그렌 증후군 진단 마커로서 ｓｉｇｌｅｃ５의 용도
KR101029004B1 (ko) 염증성 관절염 마커로서의 ｐｒｄｍ10 단백질 및 이를 포함하는 염증성 관절염 진단키트
KR101700945B1 (ko) 선천성 녹내장, 유전성 혈관 석회화 또는 골격 이상증에 대한 원인 유전자로서의 ddx58 돌연변이 유전자 및 이를 이용한 상기 질병의 진단방법 및 진단용 조성물
CN110713544A (zh) 融合基因plekha6-ntrk3及其在lch中的应用
US10213481B2 (en) Compositions and methods to treat inflammatory joint disease
JP2003530109A (ja) エルビンをコードする遺伝子及びその診断及び治療的使用
JP2010187556A (ja) 妊孕性診断方法、妊孕性診断キット、ポリヌクレオチド、ポリペプチド、及び抗体
JP2005505267A (ja) 癌において差次的に発現する膜貫通タンパク質
CN108728523B (zh) Bcl-3作为诊断早期肾纤维化的标志物的应用
JP6721571B2 (ja) １５種類の男性生殖関連タンパク質またはその組み合わせの使用
KR101727750B1 (ko) 단맛 수용체 유전자를 함유하는 허혈질환 진단용 조성물
KR100983386B1 (ko) 난소암 진단을 위한 ａｇｒ-2의 신규한 용도
US20030104418A1 (en) Diagnostic markers for breast cancer
KR102015527B1 (ko) 데스모글레인 3의 유전적 변이 및 이의 용도
JP4445291B2 (ja) 新規タンパク質およびそのｄｎａ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140723

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141020

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150122

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150603

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150629

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20151022